TAK-285

· Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-285, covering 2011-12-09 to 2011-12-09. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Pharmacokinetic Study of TAK-285 in Patients With Advanced Cancer [Phase 1]